What to expect in the Kodiak Sciences Inc. interview process

Based on information found online, Kodiak Sciences Inc. is a clinical-stage biopharmaceutical and biotechnology research company headquartered in Palo Alto, California, with additional presence in Switzerland and Canada. Founded in 2009, the mid-sized enterprise operates with a lean workforce numbering between roughly 94 and 135 employees, backed by total funding of $1 billion and a market cap around $3 billion.

Publicly available sources indicate that the company focuses heavily on research, development, and clinical trials for high-prevalence retinal diseases using its proprietary ABC Platform. Job listings, such as roles for a Manager of Clinical Data Management, point to positions requiring significant industry experience (such as 7+ years) centered on supporting clinical trial databases, electronic Case Report Forms, and regulatory submissions. Openings are structured as full-time, onsite positions based out of the Palo Alto headquarters.

Regarding talent acquisition and immigration support, employment profiles note active H-1B visa filings—including a certified labor condition application filed in fiscal year 2026—indicating that H-1B visa sponsorship is likely for qualifying candidates. ESG transparency ratings for the company indicate mixed internal metrics, reflecting lower governance and social scores alongside a higher environmental score. Because the organization functions as a clinical-stage biotech with a compact headcount of specialists, prospective employees can expect a science-driven, research-intensive environment tied directly to the clinical milestones and regulatory progress of its pipeline candidates like tarcocimab, KSI-501, and KSI-101.